Biotech Values

[jbog]

Dewophile,

Momenta had the real asset, which was the ability to design this product.

We are all guessing at the numbers at this point because Momenta has not answered all the questions that we needed to know, so in many ways we'll just have to wait.

I've been trying to decide why Momenta's stock has cratered so bad, and the only answer I can come up with is that the final numbers will be very close to my estimates. While my numbers aren't what I was hoping for, they will indeed put a nice base under Momenta so they can go forward.

Good Luck